IVERIC bio (ISEE) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
May 4, 2022 6:32 AM EDT- Zimura® GATHER2 Topline Data Expected in the Third Quarter of this Year-
- GATHER2 Trial Completion at 94% for Year One; Patient Retention Continues to Exceed Expectations with a Target 12-Month Injection Fidelity Rate of Greater than 90%
- U.S. Patent Covering Methods of Treating GA with Zimura Granted by USPTO
- Conference Call and Webcast Today, May 4, 2022, at 8:00 a.m. ET
PARSIPPANY, N.J.--(BUSINESS... More



